Selective resistance of L1210 cell lines to inhibitors directed at the subunits of ribonucleotide reductase

Advances in Enzyme Regulation

Volumn 29, Issue C, 1989, Pages 123-139

  Carter, Gay L ^a   Cory, Joseph G ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTIDINE; DNA; RIBONUCLEOTIDE REDUCTASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL FREE SYSTEM; COMPARATIVE STUDY; DRUG RESISTANCE; LEUKEMIA L 1210; METABOLISM;

ANIMAL; ANTINEOPLASTIC AGENTS; CELL-FREE SYSTEM; COMPARATIVE STUDY; CYTIDINE; DNA, NEOPLASM; DRUG RESISTANCE; LEUKEMIA L1210; RIBONUCLEOTIDE REDUCTASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0024794145     PISSN: 00652571     EISSN: None     Source Type: Journal    
DOI: 10.1016/0065-2571(89)90097-6     Document Type: Article

References (41)

1. Levels of ribonucleotide reductase activity during the division cycle of the L cell
2. Components and control of ribonucleotide reductase systems of the rat
3. Reconstitution of ribonucleotide reductase from Ehrlich tumor cells
4. Substrate specificity of human ribonucleotide reductase from Molt-4F cells
5. Cloned mouse ribonucleotide reductase subunit M1 cDNA reveals amino acid sequence homology with Escherichia coli and herpes virus ribonucleotide reductases
6. Isolation and characterization of expressible cDNA clones encoding the M1 and M2 subunits of mouse ribonucleotide reductase
7. Noncoordinate changes in the components of ribonucleotide reductase in mammalian cells
8. Ribonucleotide reductase in cultured mouse lymphoma cells. Cell cycle-dependent variation in the activity of subunit protein M2
9. Changes in the cytoplasmic and nuclear activities of the ribonucleotide reductase holoenzyme and its subunits in regenerating liver cells in normal and thyroparathyroidectomized rats
10. Effects of nucleoside triphosphates on human ribonucleotide reductase from Molt-4F cells
11. Allosteric regulation of calf thymus ribonucleoside diphosphate reductase
12. Nucleoside 5′-diphosphates as effectors of mammalian ribonucleotide reductase
13. Differential turnover of the subunits of ribonucleotide reductase in synchronized L1210 cells
14. Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapy
15. Effects of combinations of drugs having different modes of action at the ribonucleotide reductase site on the growth of L1210 cells in culture
16. Effect of combinations of deoxyguanosine and 8-aminoguanosine with 2,3-dihydro-1H-imidazo[1,2-b]pyrazole on L1210 cell growth in culture
17. Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazolo[2,3-a]imidazole
18. Effects of N-hydorxy-N′-aminoguanidine isoquinoline in combination with other inhibitors of ribonucleotide reductase on L1210 cells
19. Altered ribonucleotide reductase activity in mammalian tissue culture cells resistant to hydroxyurea
20. Isolation of hydroxyurea-resistant CHO cells with altered levels of ribonucleotide reductase
21. Overproduction of the free radical of ribonucleotide reductase in hydroxyurea-resistant mouse fibroblast 3T6 cells
22. Alterations in the components of ribonucleotide reductase in hydroxyurea-resistant hamster cells
23. Characterization of a mouse cell line selected for hydroxyurea resistance by a stepwise procedure: Drug-dependent overproduction of ribonucleotide reductase activity
24. N-carbamoyloxyurea-resistant Chinese hamster ovary cells with elevated levels of ribonucleotide reductase activity
25. Evidence of a common site of action for the antitumor drugs, hydroxyurea and guanazole
26. Deoxyadenosine metabolism and cytoxicity in cultured mouse T-lymphoma cells: A model for immunodeficiency disease
27. Alterations in deoxyribonucleotide metabolism in cultured cells with ribonucleotide reductase activities refractory to feedback inhibition by 2′-deoxyadenosine triphosphate
28. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors
29. Demonstration of normal and mutant protein M1 subunits of deoxyGTP-resistant ribonucleotide reductase from mutant mouse lymphoma cells
30. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells
31. Selection of aphidicolin-resistant CHO cells with altered levels of ribonucleotide reductase
32. Alteration of ribonucleotide reductase in aphidicolin-resistant mutants of mouse FM3A cells with associated resistance to arabinosyladenine and arabinosylcytosine
33. A rapid assay for CDP reductase activity in mammalian cell extracts
34. A convenient assay for ADP reductase using Dowex-1-borate columns
35. Effect of iron-chelating agents on inhibitors of ribonucleotide reductase
36. Inhibition of ribonucleotide reductase and L1210 cell growth by N-hydroxy-N′-aminoguanidine derivatives
37. Mechanism of inhibition of mammalian ribonucleotide reductase by the iron chelate of 1-formylisoquinoline thiosemicarbazone. Destruction of the tyrosine free-radical of an enzyme in an oxygen-requiring reaction
38. Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents
39. Altered expression of ribonucleotide reductase and role of M2 gene amplification in hydroxyurea-resistant hamster, mouse, rat and human cell lines
40. Molecular cloning of the cDNA for a mutant mouse ribonucleotide reductase M1 that produces a dominant mutator phenotype in mammalian cells